The dot-com era's accounting fraud wasn't one-sided. Professional investors and Wall Street created a symbiotic relationship with executives by demanding impossibly smooth, predictable quarterly earnings. This intense pressure incentivized widespread financial engineering and manipulation to meet unrealistic expectations.

Speculation is often maligned as mere gambling, but it is a critical component for price discovery, liquidity, and risk transfer in any healthy financial market. Without speculators, markets would be inefficient. Prediction markets are an explicit tool to harness this power for accurate forecasting.

Despite its theoretical role as a market check, short selling is often a tool to create chaos and innuendo for profit. Activist short-sellers release reports to move markets for their own gain, which rarely uncovers true malfeasance and is an extremely difficult way to consistently make money. It's more about creating narratives than finding fraud.

The company Anti-Fraud pioneers a "Snitching as a Service" model where it only earns revenue when its AI-powered investigations lead to government recovery from corporate fraud. This whistleblower-driven approach perfectly aligns incentives and provides a sustainable financial path for investigative journalism, an industry that has struggled with traditional advertising and subscription models.

Public perception sees corporate fraud as a rare, company-defining event. The reality inside Fortune 100 companies is that substantial violations occur frequently—as often as every few days. Management's job isn't to eliminate misconduct entirely, but to manage its frequency and severity to keep it small and internal.

Traditionally, whistleblowers leak information about corporate or government malfeasance to journalists. Prediction markets create an alternative path: anonymously trading on that information to make a profit, undermining the public service function of investigative reporting.

Early-stage biotech companies are vulnerable to short selling in public markets because their experiments run for 12-24 months, creating long periods without news flow. With no catalysts to drive buying ("no bid"), hedge funds can short the stocks until data is released, highlighting a structural disadvantage of being public too early.

A profitable short-selling strategy avoids simply betting against expensive stocks. Instead, it targets new product launches, where market expectations are often extremely divergent from reality. This provides a clear catalyst and a greater chance for a mispricing that can be exploited for absolute returns.

The market's negative reaction and subsequent corporate changes were not driven by regulatory action, but by the public release of documents from a survivor's lawsuit. This demonstrates that survivor testimony can directly influence markets, acting as a potent force for financial and corporate accountability.